BC ECHO on Substance Use – Opioid Use Disorder: Cycle 4, Session 3

Opioid agonist treatment and pharmacy

Thursday March 11, 2021, 12:00-1:00 PM PST

Presenter: Dr. Mona Kwong, Pharmacy Advisor & Director of Addictions Pharmacy Fellowship Program,
BC Centre on Substance Use; Clinical Pharmacist Consultant, Infinity Medical Specialists Clinic; Clinical Pharmacist and Manager, Pharmasave Howe Street

At the end of this session, you should be able to:

1. Describe opioid agonist treatment options
2. Describe methadone options covered by BC Pharmacare
3. Identify drug–drug interactions with opioid agonist treatment medications
4. Avoid common errors when writing opioid agonist treatment prescriptions
5. Describe the logistics of pharmacy opioid agonist treatment administration, including witnessed ingestion, partial dose ingestion, shortages, missed doses, carries, and prescription cancellations
6. Describe Controlled Drugs and Substances Act exemptions relevant to OAT provision (due to COVID-19)
7. Describe how PharmaNet is used in pharmacy settings, including identifying the pharmacy filling the prescription, what is seen on the system
8. Manage logistics when patients travel out of province
9. Be aware of forthcoming new BC Controlled Prescription Program forms